1994 – First patent for safety lancet in the US

2000:

DEVELOPMENT:

2004 – Introduction of lancets for personal use

2006 – Initial public offering on Warsaw Stock Exchange

2007:

2009 – EQT V (leading private equity player) ownership

2010 – Withdrawal of HTL-STREFA from Warsaw Stock Exchange (due to acquisition by the EQT V)

EXPANSION:

Two modern production facilities in Lodz Special Economic Zone, Poland
Two Sales & Marketing offices in two locations (Warsaw, Poland and Marietta, GA, USA)
5 product categories with multiple variations
Introduction of new innovative solutions into the market
Global market presence – more than 80 countries around the world

2018 – Investindustrial (leading independent European Investment Group) ownership. Integration of HTL-STREFA and PIC

Haemolance - Model Plus - Safety Lancet- Brochure